Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556

M. V. Dieci; C. Criscitiello; A. Goubar; G. Viale; P. Conte; V. Guarneri; G. Ficarra; M. C. Mathieu; S. Delaloge; G. Curigliano; F. Andre

doi:10.1093/annonc/mdv241

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556

M. V. Dieci, C. Criscitiello, A. Goubar, G. Viale, P. Conte, V. Guarneri, G. Ficarra, M. C. Mathieu, S. Delaloge, G. Curigliano, F. Andre

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1518
Number of pages	1
Journal	Annals of Oncology
Volume	26
Issue number	7
DOIs	https://doi.org/10.1093/annonc/mdv241
Publication status	Published - Jul 1 2015

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mdv241

Cite this

Dieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., C. Mathieu, M., Delaloge, S., Curigliano, G., & Andre, F. (2015). Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556. Annals of Oncology, 26(7), 1518. https://doi.org/10.1093/annonc/mdv241

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer : A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556. / Dieci, M. V.; Criscitiello, C.; Goubar, A.; Viale, G.; Conte, P.; Guarneri, V.; Ficarra, G.; C. Mathieu, M.; Delaloge, S.; Curigliano, G.; Andre, F.

In: Annals of Oncology, Vol. 26, No. 7, 01.07.2015, p. 1518.

Research output: Contribution to journal › Article › peer-review

Dieci, MV, Criscitiello, C, Goubar, A, Viale, G , Conte, P , Guarneri, V, Ficarra, G, C. Mathieu, M, Delaloge, S, Curigliano, G & Andre, F 2015, 'Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556', Annals of Oncology, vol. 26, no. 7, pp. 1518. https://doi.org/10.1093/annonc/mdv241

Dieci MV, Criscitiello C, Goubar A, Viale G , Conte P , Guarneri V et al. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556. Annals of Oncology. 2015 Jul 1;26(7):1518. https://doi.org/10.1093/annonc/mdv241

Dieci, M. V. ; Criscitiello, C. ; Goubar, A. ; Viale, G. ; Conte, P. ; Guarneri, V. ; Ficarra, G. ; C. Mathieu, M. ; Delaloge, S. ; Curigliano, G. ; Andre, F. / Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer : A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556. In: Annals of Oncology. 2015 ; Vol. 26, No. 7. pp. 1518.

@article{e545119764054b8cbbab1b2e6a7302f8,

title = "Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556",

author = "Dieci, {M. V.} and C. Criscitiello and A. Goubar and G. Viale and P. Conte and V. Guarneri and G. Ficarra and {C. Mathieu}, M. and S. Delaloge and G. Curigliano and F. Andre",

year = "2015",

month = jul,

day = "1",

doi = "10.1093/annonc/mdv241",

language = "English",

volume = "26",

pages = "1518",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "7",

}

TY - JOUR

T1 - Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer

T2 - A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556

AU - Dieci, M. V.

AU - Criscitiello, C.

AU - Goubar, A.

AU - Viale, G.

AU - Conte, P.

AU - Guarneri, V.

AU - Ficarra, G.

AU - C. Mathieu, M.

AU - Delaloge, S.

AU - Curigliano, G.

AU - Andre, F.

PY - 2015/7/1

Y1 - 2015/7/1

UR - http://www.scopus.com/inward/record.url?scp=84946706107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946706107&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv241

DO - 10.1093/annonc/mdv241

M3 - Article

AN - SCOPUS:84946706107

VL - 26

SP - 1518

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 7

ER -

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this